Use of GM-CSF Treatment in Recurrent Implantation Failure

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
The purpose of this study is to determine whether in Assisted Reproductive Technologies the treatment with GM-CSF, a growth factor working on stem cells, may improve the pregnancy rate and pregnancy outcome in patients experiencing recurrent implantation failure in IVF cycles.
Epistemonikos ID: 81e0ee7a9ed2b2c5906b4a20c49c873fdbd5561a
First added on: May 11, 2024